Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
18 oct. 2024 22h46 HE
|
Tevogen Bio Inc
WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN) is a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
Roadzen to Present at the ThinkEquity Investor Conference October 30, 2024
18 oct. 2024 09h00 HE
|
Roadzen Inc.
Roadzen to Present at the ThinkEquity Investor Conference October 30, 2024
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
18 oct. 2024 08h00 HE
|
Helius Medical Technologies, Inc.
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
Ohmyhome to Announce Q3 2024 Growth Updates
18 oct. 2024 05h00 HE
|
Ohmyhome Pte. Ltd.
Singapore, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Ohmyhome Ltd. (NASDAQ: OMH, “Ohmyhome”), a one-stop-shop property technology platform providing end-to-end property solutions and services including...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Acadia Healthcare Company, Inc.
16 oct. 2024 21h20 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Healthcare To Contact Him Directly To Discuss Their...
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
16 oct. 2024 16h15 HE
|
OncoCyte Corporation
Oncocyte Announces Participation in the LD Micro Main Event XVII
Conference in Los Angeles
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16 oct. 2024 16h05 HE
|
Optinose, Inc.
YARDLEY, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AMMO, Inc.
16 oct. 2024 11h45 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In AMMO To Contact Him Directly To Discuss Their Options If you...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Super Micro Computer
16 oct. 2024 11h38 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Super Micro Computer To Contact Him Directly To Discuss Their...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bumble Inc.
16 oct. 2024 11h37 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Bumble To Contact Him Directly To Discuss Their Options If you...